Endoscopic gastroplasty with ENDOMINA triangulation platform received innovation funding (Forfait innovation) in France

10

Jun 2022

In April 2022, the French National Authority for Health (HAS) published the draft opinion on the coverage of the endoscopic gastroplasty with the use of the ENDOMINA triangulation platform from the Endo Tools Therapeutics under the Innovation package (Forfait innovation). However, the HAS provided some recommendations regarding the modification of the study protocol that should be implemented within 30 days. The HAS opinion of April 2022 can be found here.

After the necessary changes were implemented into the protocol, on May 31, 2022, HAS published a final positive opinion on the coverage of the ENDOMINA triangulation platform under the Innovation package (Forfait innovation) with the indication for the type 2 diabetic patients suffering from so-called "moderate" class I obesity (30 ≤ body mass index (BMI) < 35 kg/m2).

More details can be found in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

06

Jul 2022

On June 22, 2022, the French Ministry of Health and Prevention published the instruction related to the 2022 application for coverage with evidence development programs. In the instruction, the specific fields of research, the application procedures, and the deadlines for applications for different types of projects (PHRC, PRME, PREPS, PHRIP, PRT) are specified.

Read more

04

Jul 2022

On June 15, 2022, the National Institute for Health and Care Excellence (NICE) announced a new program called Early Value Assessment for Medtech. The program will offer a rapid assessment of digital products, devices, and diagnostics for clinical effectiveness and value for money where the evidence base is still emerging to inform NHS commissioners. The two pilot assessments for health apps will begin in June 2022 and are expected to be published in October 2022. Further topics are expected in mental health, early cancer diagnosis, and cardiovascular disease.

Read more

29

Jun 2022

In early June 2022, NHS England and NHS Improvement updated information about the nationwide purchase and supply system for High Cost Tariff-Excluded Devices, which was introduced in 2016. The name of the program changed to the Specialised Service Devices program (SSDP). The program currently covers 15 categories of devices, and several new categories will be added during the 2022/23 financial year.

Read more

28

Jun 2022

At the end of May 2022, the new intra-DRG list was published. No major changes were introduced in the list. No new devices were added to the list.

Read more

24

Jun 2022

On June 7, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) published the overview of the 32 innovative healthcare research projects that will be funded, including those belonging to the eHealth technology group.

Read more